Elevance Health Gross Margin 2010-2024 | ELV

Current and historical gross margin for Elevance Health (ELV) over the last 10 years. The current gross profit margin for Elevance Health as of September 30, 2024 is %.
Elevance Health Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-09-30 $174.22B $30.24B 17.36%
2024-06-30 $171.96B $30.77B 17.89%
2024-03-31 $171.75B $30.02B 17.48%
2023-12-31 $171.34B $29.72B 17.34%
2023-09-30 $168.62B $29.33B 17.39%
2023-06-30 $165.71B $28.82B 17.39%
2023-03-31 $160.67B $27.84B 17.33%
2022-12-31 $156.60B $26.92B 17.19%
2022-09-30 $153.25B $26.88B 17.54%
2022-06-30 $149.13B $26.08B 17.48%
2022-03-31 $144.35B $25.78B 17.86%
2021-12-31 $138.64B $25.17B 18.16%
2021-09-30 $133.88B $24.34B 18.18%
2021-06-30 $129.22B $24.08B 18.63%
2021-03-31 $124.63B $25.09B 20.13%
2020-12-31 $121.87B $24.87B 20.41%
2020-09-30 $117.45B $24.53B 20.89%
2020-06-30 $112.97B $23.69B 20.97%
2020-03-31 $109.17B $21.20B 19.42%
2019-12-31 $104.21B $20.44B 19.61%
2019-09-30 $100.18B $20.00B 19.96%
2019-06-30 $96.76B $19.89B 20.55%
2019-03-31 $94.23B $20.10B 21.33%
2018-12-31 $92.11B $20.21B 21.94%
2018-09-30 $91.41B $19.78B 21.64%
2018-06-30 $90.59B $19.04B 21.02%
2018-03-31 $90.05B $18.31B 20.34%
2017-12-31 $90.04B $17.80B 19.77%
2017-09-30 $89.07B $17.94B 20.14%
2017-06-30 $88.05B $18.10B 20.56%
2017-03-31 $87.10B $18.26B 20.97%
2016-12-31 $84.86B $18.03B 21.24%
2016-09-30 $83.34B $17.75B 21.30%
2016-06-30 $81.84B $17.71B 21.64%
2016-03-31 $80.40B $17.87B 22.22%
2015-12-31 $79.16B $18.04B 22.79%
2015-09-30 $77.95B $18.29B 23.47%
2015-06-30 $76.61B $18.21B 23.77%
2015-03-31 $75.07B $17.75B 23.64%
2014-12-31 $73.87B $17.02B 23.04%
2014-09-30 $72.79B $16.21B 22.27%
2014-06-30 $72.09B $15.65B 21.71%
2014-03-31 $71.31B $15.16B 21.25%
2013-12-31 $71.02B $14.79B 20.82%
2013-09-30 $68.44B $14.50B 21.18%
2013-06-30 $65.94B $14.02B 21.26%
2013-03-31 $63.66B $13.47B 21.16%
2012-12-31 $61.50B $13.28B 21.60%
2012-09-30 $61.49B $13.14B 21.36%
2012-06-30 $61.54B $13.17B 21.40%
2012-03-31 $61.23B $13.04B 21.30%
2011-12-31 $60.71B $13.06B 21.52%
2011-09-30 $60.02B $13.45B 22.40%
2011-06-30 $59.19B $13.48B 22.77%
2011-03-31 $58.52B $13.74B 23.48%
2010-12-31 $58.70B $13.77B 23.46%
2010-09-30 $63.03B $17.39B 27.59%
2010-06-30 $63.89B $17.79B 27.84%
2010-03-31 $64.87B $17.78B 27.41%
2009-12-31 $64.94B $17.40B 26.79%
Sector Industry Market Cap Revenue
Medical Medical Services $84.995B $171.340B
Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana.
Stock Name Country Market Cap PE Ratio
Cencora (COR) United States $43.734B 16.44
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $20.871B 0.00
ICON (ICLR) Ireland $16.879B 15.03
Viatris (VTRS) United States $14.478B 4.46
Avantor (AVTR) United States $14.307B 21.45
Revvity (RVTY) United States $13.453B 23.37
BioMerieux (BMXMF) France $12.659B 0.00
CochLear (CHEOY) Australia $11.807B 0.00
Solventum (SOLV) United States $11.540B 0.00
Medpace Holdings (MEDP) United States $10.417B 29.35
Doximity (DOCS) United States $10.302B 60.64
Charles River Laboratories (CRL) United States $9.314B 18.00
HealthEquity (HQY) United States $8.212B 41.20
Sonic Healthcare (SKHHY) Australia $8.208B 0.00
Bausch + Lomb (BLCO) Canada $6.322B 29.43
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.759B 20.11
Organon (OGN) United States $3.719B 3.75
BrightSpring Health Services (BTSG) United States $2.967B 63.11
Surgery Partners (SGRY) United States $2.493B 28.42
Concentras Parent (CON) United States $2.491B 0.00
Ardent Health Partners (ARDT) United States $2.291B 0.00
GeneDx Holdings (WGS) United States $2.069B 0.00
Premier (PINC) United States $2.067B 10.76
PACS (PACS) United States $1.992B 0.00
Alignment Healthcare (ALHC) United States $1.969B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.730B 0.00
GoodRx Holdings (GDRX) United States $1.711B 44.90
Teladoc Health (TDOC) United States $1.544B 0.00
Pediatrix Medical (MD) United States $1.224B 11.98
Progyny (PGNY) United States $1.208B 24.47
Embecta (EMBC) United States $1.161B 8.12
CareDx (CDNA) United States $1.102B 0.00
Establishment Labs Holdings (ESTA) $1.090B 0.00
AMN Healthcare Services Inc (AMN) United States $0.874B 5.91
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.775B 0.00
SBC Medicals (SBC) United States $0.649B 0.00
Auna S.A (AUNA) Luxembourg $0.492B 0.00
InnovAge Holding (INNV) United States $0.478B 0.00
DocGo (DCGO) United States $0.444B 16.73
Sonida Senior Living (SNDA) United States $0.441B 0.00
Enhabit (EHAB) United States $0.387B 33.48
Sera Prognostics (SERA) United States $0.275B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.268B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Biodesix (BDSX) United States $0.198B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
ModivCare (MODV) United States $0.156B 8.44
MultiPlan (MPLN) United States $0.108B 0.00
Ascend Wellness Holdings (AAWH) United States $0.099B 0.00
So-Young (SY) China $0.093B 15.69
IceCure Medical (ICCM) Israel $0.052B 0.00
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeueHealth (NEUE) United States $0.033B 0.87
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Cano Health (CANOQ) United States $0.001B 0.00
Aclarion (ACON) United States $0.001B 0.00